Momelotinib Impurity 13 | CAS 454646-55-0 - Request Quote
Momelotinib Impurity 13
| SZ CAT No: | SZ-M168024 |
| CAS No | 454646-55-0 |
| Mol.F. | C12H15N5O |
| Mol.Wt. | 245.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib Impurity 13 is chemically N-Cyano-N′-[4-(4-morpholinyl)phenyl]guanidine. Momelotinib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 454646-55-0
Purchase 454646-55-0
Order 454646-55-0
Enquire 454646-55-0
price of 454646-55-0
454646-55-0 Supplier
454646-55-0 Manufacturer
454646-55-0 Exporter
buy high quality Momelotinib Impurity 13
Purchase Momelotinib Impurity 13
Momelotinib Impurity 13 suppliers
Momelotinib Impurity 13 manufacturers
Momelotinib Impurity 13 price
Order Momelotinib Impurity 13
Enquire Momelotinib Impurity 13
Momelotinib Impurity 13 cost
Momelotinib Impurity 13 Supplier
Momelotinib Impurity 13 Distributor
Momelotinib Impurity 13 for Method Validation
Momelotinib Reference Standard
Momelotinib Impurity 13 for ANDA Filing
Momelotinib Impurity 13 for Forced Degradation Studies
Momelotinib Impurity 13 Identification Standards
Momelotinib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


